Relationship between an angiotensinogen gene polymorphism (M235T) and serum lipids: A cross-sectional study among Japanese workers

Yonago Acta Medica

Volumn 49, Issue 1, 2006, Pages 49-58

  Kaetsu, Akihiko ^a   Kishimoto, Takuji ^a   Osaki, Yoneatsu ^a   Okamoto, Mikizoh ^a   Kurozawa, Yoichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; Cholesterol; Cross sectional study; Japanese workers; Polymorphism (genetics)

Indexed keywords

ANGIOTENSINOGEN;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 33645331850     PISSN: 05135710     EISSN: 05135710     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arnett DK, Borecki IB, Ludwig EH, Pankow JS, Myers R, Evans G, et al. Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies. Atherosclerosis 1998;138:111-116.
2. Batalla A, Alvarez R, Reguero JR, Hevia S, Iglesias-Cubero G, Alvarez V, et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 2000;46:1910-1915.
3. Buraczynska M, Pijanowski Z , Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, et al. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 2003;58:1-9.
4. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1633.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
6. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001;60:52-57.
7. Fernandez-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L. Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. Am J Hypertens 1998;11(4 Pt 1):439-444.
8. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995;96:295-300.
9. Frossard PM, Hill SH, Elshahat YI, Obineche EN, Bokhari AM, Lestringant GG, et al. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet 1998;54:285-293.
10. Fujiwara T, Katsuya T, Matsubara M, Mikami T, Ishikawa K, Kikuya M, et al. T+31C polymorphism of angiotensinogen gene and nocturnal blood pressure decline: the Ohasama study. Am J Hypertens 2002;15(7 Pt 1):628-632.
11. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-1287.
12. Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996;28:907-911.
13. Ichihara S, Yokota M, Fujimura T, Kato S, Hirayama H, Tsunekawa A, et al. Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men. Am Heart J 1997;134(2 Pt 1):260-265.
14. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-1797.
15. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30:1325-1330.
16. Ishigami T, Tamura K, Fujita T, Kobayashi I, Hibi K, Kihara M, et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension 1999;34:430-434.
17. Ishikawa K, Baba S, Katsuya T, Iwai N, Asai T, et al. T+31C polymorphism of angiotensinogen gene and essential hypertension. Hypertension 2001;37:281-285.
18. Iwai N, Ohmichi N, Nakamura Y, Mitsunami K, Kinoshita M. Molecular variants of the angiotensinogen gene and hypertension in a Japanese population. Hypertens Res 1994;17:117-121.
19. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25(4 Pt 2):688-693.
20. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
21. Kaetsu A, Kishimoto T, Osaki Y, Okamoto M, Fukumoto S, Kurozawa Y. The lack of relationship between an endothelin-1 gene polymorphism (Ala288ser) and incidence of hypertension: a retrospective cohort study among Japanese workers. J Epidemiol 2004;14:129-136.
22. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-1603.
23. Kishimoto T, Suyama A, Igarashi A, Osaki Y, Okamoto M, Yamamoto T, et al. Angiotensinogen gene variation and hypertension in a cohort study in Japanese. J Epidemiol 2001a;11:115-119.
24. Kishimoto T, Suyama A, Osaki Y, Miyamoto T, Igarashi A, Okamoto M, et al. A molecular variant of the angiotensinogen gene and hypertension in a case-control study in Japanese. Yonago Acta Med 2001b;44:79-83.
25. Matsubara M, Metoki H, Katsuya T, Kikuya M, Suzuki M, Michimata M, et al. T+31C polymorphism (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: the Ohasama Study. Hypertens Res 2003;26:47-52.
26. Nair KG, Shalia KK, Ashavaid TF, Dalal JJ. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003;17:141-146.
27. 235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995;13:717-722.
28. Okazaki T, Himeno E, Nanri H, Ikeda M. Effects of a community-based lifestyle-modification program on cardiovascular risk factors in middle-aged women. Hypertens Res 2001;24:647-653.
29. Robinson MT, Wilson TW, Nicholson GA, Grell GA, Etienne C, Grim CM, et al. AGT and RH blood group polymorphisms affect blood pressure and lipids in Afro-Caribbeans. J Hum Hypertens 2004;18:351-363.
30. Rodriguez-Perez JC, Rodriguez-Esparragon FJ, Hernandez-Perera O, Fiuza-Perez MD, Anabitarte-Prieto A, Losada-Cabrera A. Effects of the angiotensinogen gene M235T and A(-6)G variants on blood pressure and other vascular risk factors in a Spanish population. J Hum Hypertens 2000;14:789-793.
31. Saito Y. Editorial. J Atheroscler Thromb 2004;11:101-103.
32. Saruta T. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Nippon Rinsho 2005;63:952-958 (in Japanese with English abstract).
33. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Miki T, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997;30(3 Pt 1):321-325.
34. Singh BM, Mehta JL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med 2003;163:1296-1304.
35. Strazzullo P, Galletti F. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism. Curr Opin Nephrol Hypertens 2004;13:325-332.
36. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 2001;24:356-361.
37. Tiago AD, Samani NJ, Candy GP, Brooksbank R, Libhaber EN, Sareli P, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002;106:1483-1487.
38. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995;13:311-317.
39. Vasku A, Soucek M, Tschoplova S, Stejskalova A. An association of BMI with A (-6) G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens 2002;16:427-430.
40. Wang WY, Glenn CL, Zhang W, Benjafield AV, Nyholt DR, Morris BJ. Exclusion of angiotensinogen gene in molecular basis of human hypertension: sib-pair linkage and association analyses in Australian anglo-caucasians. Am J Med Genet 1999;87:53-60.
41. Wierzbicki AS, Lambert-Hammill M, Lumb PJ, Crook MA. Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia. Hypertension 2000;36:808-812.
42. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus. Geneva: World Health organization; 1999.